ADXN
Addex Therapeutics Ltd
NASDAQ: ADXN · HEALTHCARE · BIOTECHNOLOGY
$7.00
+3.86% today
Updated 2026-04-29
Market cap
$8.62M
P/E ratio
—
P/S ratio
54.40x
EPS (TTM)
$-9.17
Dividend yield
—
52W range
$5 – $12
Volume
0.0M
Addex Therapeutics Ltd (ADXN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $46.35M | $149.37M | $132.33M | $88.55M | $74.28M | $43.62M | $21.74M | $5.88M | $4.00M | $2.89M | $1.68M | $3.06M | $42.21M | $33.03M | $20.18M | $22.54M | $8.28M | $4.64M | $10.68M |
| Cash & equivalents | $40.95M | $140.04M | $119.47M | $76.56M | $63.80M | $36.07M | $15.26M | $2.91M | $1.98M | $2.63M | $1.42M | $2.59M | $41.67M | $31.54M | $18.70M | $20.48M | $6.96M | $3.87M | $3.34M |
| Current assets | $42.26M | $143.68M | $122.60M | $78.40M | $66.50M | $38.07M | $17.02M | $3.90M | $2.14M | $2.78M | $1.66M | $3.05M | $42.15M | $32.39M | $19.49M | $21.94M | $7.83M | $4.23M | $3.54M |
| Total liabilities | $4.07M | $9.27M | $13.34M | $10.97M | $9.87M | $9.78M | $5.44M | $2.85M | $1.65M | $1.23M | $1.46M | $1.72M | $2.97M | $7.50M | $5.57M | $5.61M | $3.37M | $3.50M | $1.00M |
| Current liabilities | $4.07M | $9.27M | $13.34M | $10.89M | $9.28M | $8.73M | $4.66M | $2.36M | $1.51M | $1.03M | $1.25M | $1.48M | $2.33M | $5.68M | $3.62M | $4.13M | $3.28M | $2.89M | $802093.00 |
| Long-term debt | — | — | — | — | — | — | — | — | $0.00 | $0.00 | — | — | — | — | — | — | — | — | — |
| Shareholder equity | $42.28M | $140.11M | $118.99M | $77.58M | $64.41M | $33.84M | $16.29M | $3.03M | $2.35M | $1.66M | $218592.00 | $1.34M | $39.24M | $25.52M | $14.61M | $16.93M | $4.91M | $1.15M | $9.68M |
| Retained earnings | $-64.44M | $-99.53M | $-121.59M | $-164.28M | $-197.93M | $-229.07M | $-256.09M | $-272.01M | $-273.79M | $-277.99M | $-281.14M | $-284.42M | $-286.07M | $-300.85M | $-313.71M | $-329.06M | $-349.86M | $-360.42M | $-353.36M |
| Accounts receivable | — | — | — | — | — | — | $982467.00 | $811549.00 | $91507.00 | $132075.00 | $220723.00 | $303882.00 | $273016.00 | $118028.00 | $68373.00 | $324421.00 | $598316.00 | $151268.00 | $15513.00 |
| Inventory | — | — | — | — | — | — | $1.00 | $1.00 | $0.00 | $0.00 | — | $1.00 | — | $-13968.00 | $162839.00 | $1.00 | $-871.60M | — | — |
| Goodwill | — | — | — | — | — | — | — | — | $0.00 | $0.00 | — | — | — | — | — | — | — | — | — |